We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Exosome Research Market: Growth, Size, Share, and Trends

Report Code BT 6939
Published in Jun, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030

Overview

The global exosome research market, valued at US$189.4 million in 2024, stood at US$214.4 million in 2025 and is projected to advance at a resilient CAGR of 17.5% from 2025 to 2030, culminating in a forecasted valuation of US$480.6 million by the end of the period. The expansion of the exosome research market is primarily fueled by several key factors, including heightened investment in pharmaceutical & life sciences research, a growing incidence of cancer, and a rising interest in exosome-based methodologies for diagnostics and therapeutics. Nevertheless, the intricate technical challenges associated with exosome isolation and existing technological constraints are likely to impede the market's growth trajectory.

Exosome Research Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Exosome Research Market

Asia Pacific

The growth of the Asia Pacific exosome research market is primarily due to the growing biomedical industry, increasing life science research, and rising investments by pharmaceutical & biotechnology companies in this region.

Growth in this market is primarily driven by the increasing R&D fundings in life science research.

Rising focus on increasing exosome-based therapies in biopharmaceutical companies is likely to offer potential growth opportunities in the market.

The uncertainty in the regulation of exosome research restrains the market growth.

The Asia Pacific market is estimated to grow at the third highest CAGR during the forecast period.

Global Exosome Research Market Dynamics

DRIVER: Increasing development of cancer therapeutics and diagnostics

The rising global prevalence of cancer is underscoring a critical need for advanced diagnostic and therapeutic solutions. In this context, exosome technologies are emerging as a groundbreaking tool, offering a non-invasive alternative for the detection, monitoring, and potential treatment of a wide array of cancers. Exosomes are tiny extracellular vesicles, generally ranging from 30 to 150 nanometers in diameter, that are secreted by various cell types into body fluids such as blood, urine, and saliva. They serve as carriers of essential molecular information—including proteins, lipids, RNA, and even genetic material—reflecting the physiological and pathological state of their cells of origin. This unique feature makes exosomes highly valuable for a variety of applications in oncology, particularly for early disease detection, treatment monitoring, and the implementation of personalized medicine approaches. The integration of exosome technologies into liquid biopsy—a minimally invasive diagnostic method—has been gaining traction due to the exosomes' inherent stability and their ability to preserve molecular content over time. This stability enables the detection of biomarkers with a high degree of accuracy, which is critical for early intervention and tailoring treatment regimens to individual patients based on their specific molecular profiles. As ongoing research delves deeper into the characterization and functional roles of exosomes, their application in diagnostics and therapeutics is expected to expand significantly. From serving as biomarkers for early detection to potentially functioning as vehicles for targeted drug delivery, exosome-based platforms are poised to make substantial contributions to advancing precision cancer care. With the potential to transform the landscape of oncology, these technologies could significantly improve patient outcomes and quality of life as the field continues to evolve.

RESTRAINT: Technical complexity of exosome isolation

Exosomes pose considerable challenges in both their isolation and characterization due to their inherent heterogeneity, which includes variability in size, molecular composition, and type of cargo they carry. Exosomes, which are a subtype of extracellular vesicles, require precise differentiation from other EV types and biological contaminants to ensure high levels of purity and specificity. This distinction is critical because, without it, the validity of research findings can be compromised. Currently, there is a notable absence of a universally accepted standard protocol for the isolation of exosomes. This lack of standardized methods contributes to significant inconsistencies across various studies, creating obstacles when attempting to directly compare results or formulate reliable conclusions. Such variability not only hampers the progress in basic research but also slows down the transition of findings to practical applications, particularly in clinical settings. The process of isolating exosomes from complex biological samples often necessitates the use of sophisticated techniques, which can include ultracentrifugation, size-exclusion chromatography, and various affinity-based capture methods. Each of these methods comes with its own set of advantages and disadvantages. For example, ultracentrifugation is widely used for its ability to yield high quantities of exosomes, yet it may also result in the co-isolation of contaminants. Size-exclusion chromatography can provide a more gentle separation, reducing the likelihood of damage to the exosomes, but it typically yields lower amounts. Affinity-based capture methods, while highly specific, may require prior knowledge of surface markers on exosomes, which could limit their generalizability. These trade-offs greatly influence the subsequent applications of isolated exosomes. For instance, in translational research, where the goal is to apply laboratory findings to clinical contexts, the yield, purity, and reproducibility of exosome isolation can significantly impact experimental outcomes and the reliability of proposed therapeutic or diagnostic uses. Ultimately, addressing these challenges in exosome research is crucial for advancing our understanding of their biological functions and potential roles in health and disease.

 

OPPORTUNITY: Increasing demand for personalized medicines

Exosome research is gaining significant traction as the field of precision medicine evolves and expands. Exosomes are small extracellular vesicles released by a variety of cells in the body. These particles play a crucial role in cell communication, carrying critical information about the state and health of the originating cells. Because of their unique properties, exosomes have emerged as valuable biomarkers for disease tracking, offering a non-invasive alternative to traditional diagnostic methods that often require surgical procedures or other invasive techniques. Exosomes intrigue in the context of disease management is their ability to encapsulate and transport proteins, lipids, and nucleic acids, which reflect the physiological state of the cells from which they originate. These characteristics position exosomes as powerful tools in identifying the early stages of diseases, including cancer, by enabling the monitoring of disease progression and response to therapies. In oncology and various other diseases, it has been observed that some cancer cells develop resistance to conventional therapies. These resistant cells often secrete exosomes containing specific proteins or molecular signatures that contribute to their survival and the mechanisms of drug resistance. By studying these exosomes, researchers can gain insights into the pathophysiology of tumors and understand how they adapt and evade treatment. This knowledge is essential for optimizing therapeutic strategies, allowing for more effective targeting of resistant cancer cells and enhancing the likelihood of treatment success. Recent advancements in technology, including high-resolution imaging and sophisticated molecular analysis techniques, are facilitating a more detailed exploration of exosomes. These innovative tools are not only improving our understanding of exosome biology but also enhancing our ability to match treatments to patients on an individual basis. Ultimately, this research holds the promise of developing personalized treatment regimens that minimize adverse effects, improving overall patient outcomes while potentially paving the way for groundbreaking therapies that are fine-tuned to the specific needs of each individual.

CHALLENGES: Limited understanding of cargo loading

A significant challenge in exosome research lies in the incomplete elucidation of the selective cargo loading mechanisms. While it is acknowledged that various biological pathways influence the incorporation of proteins, nucleic acids, and lipids into exosomes, the specific regulatory processes remain inadequately characterized. The preferential inclusion of certain biomolecules over others is not well defined, adding to the heterogeneity of exosomal composition across diverse cell types and experimental conditions. To enhance the therapeutic potential of exosomes, it is crucial to intensify research and development efforts aimed at delineating these loading mechanisms. Such insights would enable researchers to exert greater control over the cargo composition of exosomes, allowing for the design of exosomes tailored to deliver specific drugs or biomarkers. Furthermore, without a comprehensive understanding of the natural sorting mechanisms, engineering exosomes for consistent outcomes poses significant challenges, thereby limiting their applicability in clinical settings such as targeted drug delivery, gene therapy, and diagnostic platforms.

Global Exosome Research Market Ecosystem Analysis

The ecosystem of exosome research consists of end users from pharmaceutical & biotechnology companies, academic & research institutes, and hospital & clinical laboratories. Exosome research product and service providers, reagent & kits suppliers, technology providers, data management & analysis providers, regulatory authorities (ensuring compliance and safety), and collaborative networks promoting knowledge sharing and collaboration. These stakeholders interact and collaborate to drive the advancement of base editing products and services, enhance drug discovery processes, and develop new therapeutics.

Exosome Research Market Ecosystem
 

Reagents & Kits commanded the largest market share, by offering, in 2024.

The exosome research market is categorized by offerings such as reagents and kits, instruments, and services. In 2024, the most significant market share was held by the reagents and kits segment. This category encompasses a variety of products, including antibodies, isolation kits, purification kits, quantitation kits, and other associated reagents. Reagents have emerged as the preferred option in exosome research workflows, owing to their enhanced efficiency and user-friendliness across various phases of project execution. Engineered for scalability, these reagents accommodate a wide spectrum of research conditions and sample volumes, rendering them indispensable in both academic settings and high-throughput industrial laboratories. Ongoing advancements in the sensitivity, specificity, and reproducibility of these reagents have facilitated their increased utilization. Furthermore, their compatibility with diverse instruments and workflows reinforces their critical role as essential consumables, substantially contributing to the evolution of exosome-based diagnostics and therapeutic applications.

The academic & research institutes segment is expected to register the highest growth rate during the forecast period.

The exosome research market is categorized by end user, including academic & research institutions, pharmaceutical & biotechnology companies, and hospitals & clinical testing laboratories. Projections for 2024 indicate that academic & research institutions have experienced the highest growth rate during the forecast period; this surge is largely attributed to the increasing momentum in exosome research, particularly regarding their roles in diagnostics, targeted drug delivery, and regenerative medicine. Researchers are delving into exosomes as efficient carriers of molecular payloads, analyzing their potential for disease detection and the delivery of therapeutics or genetic material. This heightened focus has spurred numerous academic investigations aimed at utilizing exosomes as both biomarkers and therapeutic modalities. Additionally, government funding and strategic collaborations with industry partners have significantly bolstered research initiatives in this domain. Consequently, academic and research institutions are pivotal in propelling advancements in exosome biology, thus facilitating future innovations in the field.

 

North America accounted for the largest regional market share in 2024.

The exosome research market is organized into several key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America emerges as the leader in market share, primarily due to its well-established research infrastructure and significant financial investment in scientific and medical innovation. In North America, the combination of extensive government initiatives and private-sector funding plays a crucial role in promoting biomedical research, which includes a strong focus on exosome research. Various federal agencies, universities, and private organizations collaborate to support advancements in this field, facilitating a conducive environment for academic institutions and pharmaceutical companies to invest in the study of exosomes. This financial backing allows researchers to explore new diagnostic methods and therapeutic applications, fostering groundbreaking discoveries. Furthermore, North America benefits from a historically favorable regulatory environment that encourages innovation within the life sciences and biotechnology sectors. Federal funding programs and grants are specifically designed to stimulate research and development, ensuring that the exploration of exosomes and their potential uses in medicine continues to expand. As a result of these factors, North America retains a dominant position in the exosome research market, followed closely by Europe, which accounts for the second largest market share owing to its own robust research initiatives and funding mechanisms.

Exosome Research Market Region
NORTH AMERICA COMMANDED HIGHEST MARKET SHARE IN 2024
US IS THE FASTEST-GROWING MARKET IN NORTH AMERICA

Recent Developments of Exosome Research Market

  • In January 2025, MLTENYI BIOTEC launched the MACSPlex EV Kit MSC (for Mesenchymal stem cells) that detects 37 EV (extracellular vesicle) surface epitopes plus two isotype controls. The MACSPlex EV Kit MSC comprises a cocktail of various fluorescently labeled bead populations, each coated with a specific antibody binding the respective surface epitopes.
  • In July 2024, Malvern Panalytical provided advanced analytical solutions for the characterization of nanoparticles, including exosomes. The company has acquired Micromeritics to broaden the physical characterization of particles, powders, and porous material portfolio in the market.
  • In December 2023, MLTENYI BIOTEC launched the MACSPlex EV Kit Neuro (for neurobiology) for the detection and characterization of extracellular vesicles (EVs), such as exosomes, using 37 different surface epitopes and two isotype controls.
  • In October 2022, Lonza expanded its cell and gene therapies (CGT) process and analytical development laboratories at its locations in Houston (US) and Geleen (NL). This further strengthened Lonza’s global process development service offering by adding capabilities and capacity to its existing laboratories.

Key Market Players

Want to explore hidden markets that can drive new revenue in Exosome Research Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD)
Segments covered Offerings, Application, Manufacturing Service, End User, Region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions (FAQ)

Who are the key players in the Exosome research market?

Key players include Thermo Fisher Scientific, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Danaher Corporation (US), Bio-Techne (US), among others.

Which offering segment dominates the Exosome research market?

The kits & reagents segment dominates the market, driven by increased interest in exosome-based procedures and rising R&D activities.

Which application segment dominated the market in 2024?

The biomarkers segment led the market in 2024, mainly due to the rising prevalence of cancer and the use of exosomes in cancer detection and diagnosis.

Which end user segment of the Exosome research market accounted for the largest market share in 2024?

The academic & research institute segment held the largest share in 2024, supported by growing investments in pharmaceutical R&D and life sciences.

What is the size and growth rate of the Exosome research market?

The market is projected to grow at a CAGR of 17.5%, from USD 214.4 million in 2025 to USD 480.6 million by 2030.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Exosome Research Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
31
RESEARCH METHODOLOGY
36
EXECUTIVE SUMMARY
49
PREMIUM INSIGHTS
53
MARKET OVERVIEW
56
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing investment in pharmaceutical and life sciences R&D
    - Rising focus on development of cancer therapeutics and diagnostics
    - Growing interest in exosome-based procedures
    RESTRAINTS
    - Technical complexity of exosome isolation and characterization
    - Regulatory complications and uncertainty in exosome research
    OPPORTUNITIES
    - High investments in emerging economies
    - Growing interest in exosome-based therapeutics
    - Rising demand for personalized medicines
    CHALLENGES
    - Lack of standard protocols for exosome manufacturing and development
    - Limited understanding of cargo loading capacity
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 PRICING ANALYSIS
    INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY KEY PLAYER, 2024
    INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION, 2024
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Ultracentrifugation
    - Nanoparticle tracking analysis (NTA)
    COMPLIMENTARY TECHNOLOGIES
    - Microfluidics
    - Western blotting/ELISA
    ADJACENT TECHNOLOGIES
    - Next-generation sequencing
    - Mass spectrometry
  • 5.9 PATENT ANALYSIS
    NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
    LIST OF KEY PATENTS, 2023–2024
  • 5.10 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.11 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.14 INVESTMENT & FUNDING SCENARIO
  • 5.15 TRADE DATA ANALYSIS
    IMPORT DATA FOR HS CODE 3822, 2020–2024
    EXPORT DATA FOR HS CODE 3822, 2020–2024
  • 5.16 IMPACT OF AI/GEN AI ON EXOSOME RESEARCH MARKET
  • 5.17 IMPACT OF 2025 US TARIFF ON EXOSOME RESEARCH MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACTS ON COUNTRY/REGION
    - North America
    - Europe
    - Asia Pacific
    IMPACT ON END-USE INDUSTRIES
    - Academic & research institutes
    - Pharmaceutical & biotechnology companies
    - Hospitals & clinical laboratories
EXOSOME RESEARCH MARKET, BY OFFERING
101
  • 6.1 INTRODUCTION
  • 6.2 KITS & REAGENTS
    ANTIBODIES
    - High demand for exosome-based markers for disease detection to propel market growth
    ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS
    - Availability of rapid and easy-to-use kits & reagents to ensure sustained demand
    OTHER KITS & REAGENTS
  • 6.3 INSTRUMENTS
    DEMAND FOR SCALABLE EXOSOME DEVELOPMENT THROUGH HIGH-THROUGHPUT SYSTEMS TO DRIVE GROWTH
  • 6.4 SERVICES
    LACK OF IN-HOUSE RESOURCES TO SUPPORT MARKET GROWTH
EXOSOME RESEARCH MARKET, BY INDICATION
119
  • 7.1 INTRODUCTION
  • 7.2 CANCER
    LUNG CANCER
    - Increasing demand for advanced diagnostics for lung cancer to propel market growth
    BREAST CANCER
    - Increased awareness and focus on better non-invasive diagnosis to aid market growth
    PROSTATE CANCER
    - Effectiveness of liquid biopsy in detecting prostate cancer before surgery to support market growth
    COLORECTAL CANCER
    - Rising focus on exosome-based research on tumor initiation, progression, chemoresistance, and metastasis to drive market
    OTHER CANCERS
  • 7.3 NEURODEGENERATIVE DISEASES
    INCREASED APPLICATION OF SALIVARY EXOSOMAL CARGO CONTENT IN DISEASE TREATMENT TO PROPEL MARKET GROWTH
  • 7.4 CARDIOVASCULAR DISEASES
    GREATER RESEARCH FOCUS ON EXTRACELLULAR VESICLES TO AUGMENT MARKET GROWTH
  • 7.5 INFECTIOUS DISEASES
    POTENTIAL FOR EXOSOMES IN DEVELOPING NOVEL INFECTIOUS DISEASE TREATMENTS TO AID ADOPTION
  • 7.6 OTHER INDICATIONS
EXOSOME RESEARCH MARKET, BY APPLICATION
147
  • 8.1 INTRODUCTION
  • 8.2 BIOMARKERS
    ABILITY TO MODULATE CELL SIGNALING AND REDUCE NEUROINFLAMMATION TO DRIVE ADOPTION
  • 8.3 VACCINE DEVELOPMENT
    NEED FOR COMBATING INFECTIOUS DISEASES TO SPUR ADOPTION OF EXOSOME-BASED VACCINES
  • 8.4 TISSUE REGENERATION
    MINIMAL SIDE EFFECTS AND HIGH EFFICACY OF EXOSOMES IN TISSUE REGENERATION TO SUPPORT ADOPTION
  • 8.5 OTHER APPLICATIONS
EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE
160
  • 9.1 INTRODUCTION
  • 9.2 STEM CELL-DERIVED EXOSOME MANUFACTURING
    INCREASE IN DEMAND FOR MESENCHYMAL STEM CELLS-BASED EXOSOMES IN THERAPEUTICS TO AUGMENT MARKET GROWTH
  • 9.3 DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING
    SIGNIFICANT DEVELOPMENTS IN DENDRITIC CELL-BASED EXOSOME IMMUNOTHERAPY TO DRIVE MARKET
  • 9.4 OTHER MANUFACTURING SERVICES
EXOSOME RESEARCH MARKET, BY END USER
163
  • 10.1 INTRODUCTION
  • 10.2 ACADEMIC & RESEARCH INSTITUTES
    INCREASING NUMBER OF CANCER AND STEM CELL RESEARCH PROJECTS GLOBALLY TO AUGMENT MARKET GROWTH
  • 10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    HIGH INVESTMENTS AND RAPID INNOVATIONS IN EXOSOME-BASED DIAGNOSTICS TO AID MARKET GROWTH
  • 10.4 HOSPITALS & CLINICAL TESTING LABORATORIES
    RISING ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO PROPEL MARKET GROWTH
EXOSOME RESEARCH MARKET, BY REGION
173
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC ANALYSIS FOR NORTH AMERICA
    US
    - US to dominate North American exosome research market during study period
    CANADA
    - Increasing funding for genome-based medical treatments to support market growth
  • 11.3 EUROPE
    MACROECONOMIC ANALYSIS FOR EUROPE
    GERMANY
    - Advanced biotechnology sector and developed research facilities to favor market growth
    UK
    - Favorable R&D initiatives and advanced life science industry to drive market
    FRANCE
    - Increasing collaborations between biotechnology firms and research institutes to propel market growth
    ITALY
    - Favorable government policies to propel growth of exosome research
    SPAIN
    - Increased focus on pharmaceutical R&D to aid market growth
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC ANALYSIS FOR ASIA PACIFIC
    CHINA
    - Favorable government initiatives for development of biotechnology industry to drive market
    JAPAN
    - High prevalence of cancer and increased healthcare expenditure to aid market growth
    INDIA
    - Increasing number of institutional alliances and growing focus on clinical innovation to support market growth
    AUSTRALIA
    - Substantial government funding and innovative applications in regenerative medicines to augment market growth
    SOUTH KOREA
    - Favorable government initiatives and routine clinical trials to support market growth
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC ANALYSIS FOR LATIN AMERICA
    BRAZIL
    - Increased government investments in pharmaceutical R&D to drive market
    MEXICO
    - Advancements in regenerative medicines and exosome-based therapies to support market growth
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    MACROECONOMIC ANALYSIS FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Strong focus on local pharmaceutical R&D to fuel market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
250
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EXOSOME RESEARCH MARKET
  • 12.3 REVENUE ANALYSIS, 2020–2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Offering footprint
    - Indication footprint
    - Application footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SME players, by offering and region
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
270
  • 13.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    QIAGEN
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    LONZA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    DANAHER
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BIO-TECHNE
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    SYSTEM BIOSCIENCES, LLC
    - Business overview
    - Products/Services/Solutions offered
    AMSBIO
    - Business overview
    - Products/Services/Solutions offered
    ROOSTERBIO, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MILTENYI BIOTEC
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    NORGEN BIOTEK CORP.
    - Business overview
    - Products/Services/Solutions offered
    AETHLON MEDICAL, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.
    - Business overview
    - Products/Services/Solutions offered
    SPECTRIS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    NANOFCM, INC.
    - Business overview
    - Products/Services/Solutions offered
    IZON SCIENCE LIMITED
    - Business overview
    - Products/Services/Solutions offered
    CAPRICOR THERAPEUTICS, INC.
    - Business overview
    - Products/Services/Solutions offered
  • 13.2 OTHER PLAYERS
    ANJARIUM BIOSCIENCES AG
    CILOA
    INNOVAPREP
    ILIAS BIOLOGICS INC.
    UNCHAINED LABS
    RION INC.
    CELL GUIDANCE SYSTEM LLC
    INOVIQ
    NX PHARMAGEN
    EXOPHARM
    EVERZOM
    NANOSOMIX
    CREATIVE BIOLABS
APPENDIX
317
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 EXOSOME RESEARCH MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 EXOSOME RESEARCH MARKET: RISK ANALYSIS
  • TABLE 4 EXOSOME RESEARCH MARKET: IMPACT ANALYSIS
  • TABLE 5 GLOBAL CANCER INCIDENCE, BY REGION, 2022 VS. 2025
  • TABLE 6 INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY KEY PLAYER, 2024
  • TABLE 7 INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION, 2024 (USD)
  • TABLE 8 EXOSOME RESEARCH MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 EXOSOME RESEARCH MARKET: NUMBER OF PATENTS FILED, 2014–2024
  • TABLE 10 EXOSOME RESEARCH MARKET: DETAILED ANALYSIS OF KEY PATENTS, 2023–2024
  • TABLE 11 EXOSOME RESEARCH MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES
  • TABLE 17 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • TABLE 18 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 19 IMPORT DATA FOR HS CODE 3822, 2020–2024 (USD THOUSAND)
  • TABLE 20 EXPORT DATA FOR HS CODE 3822, 2020–2024 (USD THOUSAND)
  • TABLE 21 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 22 EXOSOME RESEARCH PRODUCTS-RELATED TARIFF REVISION
  • TABLE 23 EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 24 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 25 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 26 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 30 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 31 ANTIBODIES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 32 NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 34 ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 MIDDLE EAST & AFRICA: ANTIBODIES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 37 ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 38 NORTH AMERICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 EUROPE: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 LATIN AMERICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 MIDDLE EAST & AFRICA: ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 43 OTHER KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 EUROPE: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 LATIN AMERICA: OTHER KITS & REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 MIDDLE EAST & AFRICA: OTHER KITS & REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 49 EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 50 NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 LATIN AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 MIDDLE EAST & AFRICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 55 EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 56 NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 LATIN AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 MIDDLE EAST & AFRICA: EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 61 EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 62 EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 68 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 69 LUNG CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 EUROPE: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 LATIN AMERICA: LUNG CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: LUNG CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 75 BREAST CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 EUROPE: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: BREAST CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA: BREAST CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 81 PROSTATE CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 EUROPE: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 85 LATIN AMERICA: PROSTATE CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: PROSTATE CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 87 COLORECTAL CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA: COLORECTAL CANCER MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: COLORECTAL CANCER MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 93 OTHER CANCERS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 95 EUROPE: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 LATIN AMERICA: OTHER CANCERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA: OTHER CANCERS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 99 EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 100 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 101 EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 103 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 105 EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 106 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
  • TABLE 107 EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
  • TABLE 108 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION)
  • TABLE 109 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030(USD MILLION))
  • TABLE 110 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2030(USD MILLION)
  • TABLE 111 EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 112 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 113 EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 115 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 116 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 117 EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 119 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 121 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 122 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 123 EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 124 EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 125 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 126 EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 128 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA & AFRICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 130 EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 131 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 132 EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 134 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 136 EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 138 EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 140 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 141 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 142 EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 144 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 146 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 148 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE, 2023–2030 (USD MILLION)
  • TABLE 149 EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 150 EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 151 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 152 EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 156 EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 157 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 158 EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 160 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 162 EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 163 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 164 EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 166 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 168 EXOSOME RESEARCH MARKET: KEYWORD RELEVANCE, TREND, AND PRIMARY FOCUS, 2015–2024
  • TABLE 169 EXOSOME RESEARCH MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 170 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 171 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 172 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 173 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 175 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 178 US: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 179 US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 US: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 181 US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 183 US: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 184 CANADA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 185 CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 186 CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 187 CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 189 CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 190 EUROPE: KEY MACROINDICATORS
  • TABLE 191 EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 192 EUROPE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 193 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 195 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 197 EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 198 GERMANY: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 199 GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 200 GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 201 GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 202 GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 203 GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 204 UK: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 205 UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 207 UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 209 UK: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 210 FRANCE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 211 FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 213 FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 215 FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 216 ITALY: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 217 ITALY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 218 ITALY: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 219 ITALY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 220 ITALY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 221 ITALY: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 222 SPAIN: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 223 SPAIN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 SPAIN: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 225 SPAIN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 SPAIN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 227 SPAIN: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 228 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 229 REST OF EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 231 REST OF EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 232 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 233 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 234 ASIA PACIFIC: KEY MACROINDICATORS
  • TABLE 235 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 242 CHINA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 243 CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 244 CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 245 CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 247 CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 248 JAPAN: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 249 JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 251 JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 252 JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 253 JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 254 INDIA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 255 INDIA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 256 INDIA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 257 INDIA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 INDIA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 259 INDIA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 260 AUSTRALIA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 261 AUSTRALIA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 262 AUSTRALIA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 263 AUSTRALIA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 264 AUSTRALIA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 265 AUSTRALIA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 266 SOUTH KOREA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 267 SOUTH KOREA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 268 SOUTH KOREA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 269 SOUTH KOREA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 270 SOUTH KOREA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 271 SOUTH KOREA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 272 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 273 REST OF ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 278 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 279 LATIN AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 280 LATIN AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 281 LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 282 LATIN AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 283 LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 284 LATIN AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 285 LATIN AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 286 BRAZIL: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 287 BRAZIL: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 288 BRAZIL: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 289 BRAZIL: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 290 BRAZIL: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 291 BRAZIL: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 292 MEXICO: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 293 MEXICO: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 294 MEXICO: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 295 MEXICO: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 MEXICO: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 297 MEXICO: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 298 REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 299 REST OF LATIN AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 300 REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 301 REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 302 REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 304 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 305 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 306 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 307 MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 308 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 309 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 310 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 311 MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 312 GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 313 GCC COUNTRIES: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 314 GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 315 GCC COUNTRIES: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 316 GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 317 GCC COUNTRIES: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 318 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 319 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 320 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2023–2030 (USD MILLION)
  • TABLE 321 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 322 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 323 REST OF MIDDLE EAST & AFRICA: EXOSOME RESEARCH MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 324 OVERVIEW OF MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN EXOSOME RESEARCH MARKET, JANUARY 2022–MAY 2025
  • TABLE 325 EXOSOME RESEARCH MARKET: DEGREE OF COMPETITION
  • TABLE 326 EXOSOME RESEARCH MARKET: REGION FOOTPRINT
  • TABLE 327 EXOSOME RESEARCH MARKET: OFFERING FOOTPRINT
  • TABLE 328 EXOSOME RESEARCH MARKET: INDICATION FOOTPRINT
  • TABLE 329 EXOSOME RESEARCH MARKET: APPLICATION FOOTPRINT
  • TABLE 330 EXOSOME RESEARCH MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 331 EXOSOME RESEARCH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SME PLAYERS, BY OFFERING AND REGION, 2024
  • TABLE 332 EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025
  • TABLE 333 EXOSOME RESEARCH MARKET: DEALS, JANUARY 2022–MAY 2025
  • TABLE 334 EXOSOME RESEARCH MARKET: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 335 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 336 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 337 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 338 QIAGEN: COMPANY OVERVIEW
  • TABLE 339 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 340 QIAGEN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 341 LONZA: COMPANY OVERVIEW
  • TABLE 342 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 343 LONZA: DEALS, JANUARY 2022–MAY 2025
  • TABLE 344 LONZA: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 345 DANAHER: COMPANY OVERVIEW
  • TABLE 346 DANAHER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 347 DANAHER: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 348 DANAHER: DEALS, JANUARY 2022–MAY 2025
  • TABLE 349 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 350 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 351 BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 352 SYSTEM BIOSCIENCES, LLC: COMPANY OVERVIEW
  • TABLE 353 SYSTEM BIOSCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 354 AMSBIO: COMPANY OVERVIEW
  • TABLE 355 AMSBIO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 356 ROOSTERBIO, INC.: COMPANY OVERVIEW
  • TABLE 357 ROOSTERBIO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 358 ROOSTERBIO, INC.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 359 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 360 MILTENYI BIOTEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 361 MILTENYI BIOTEC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 362 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
  • TABLE 363 NORGEN BIOTEK CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 364 AETHLON MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 365 AETHLON MEDICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 366 AETHLON MEDICAL, INC.: PRODUCT APPROVALS, JANUARY 2022–MAY 2025
  • TABLE 367 CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: COMPANY OVERVIEW
  • TABLE 368 CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 369 SPECTRIS: COMPANY OVERVIEW
  • TABLE 370 SPECTRIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 371 SPECTRIS: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 372 SPECTRIS: DEALS, JANUARY 2022–MAY 2025
  • TABLE 373 NANOFCM, INC.: COMPANY OVERVIEW
  • TABLE 374 NANOFCM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 375 IZON SCIENCE LIMITED: COMPANY OVERVIEW
  • TABLE 376 IZON SCIENCE LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 377 CAPRICOR THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 378 CAPRICOR THERAPEUTICS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 379 ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW
  • TABLE 380 CILOA: COMPANY OVERVIEW
  • TABLE 381 INNOVAPREP: COMPANY OVERVIEW
  • TABLE 382 ILIAS BIOLOGICS INC.: COMPANY OVERVIEW
  • TABLE 383 UNCHAINED LABS: COMPANY OVERVIEW
  • TABLE 384 RION INC.: COMPANY OVERVIEW
  • TABLE 385 CELL GUIDANCE SYSTEM LLC: COMPANY OVERVIEW
  • TABLE 386 INOVIQ: COMPANY OVERVIEW
  • TABLE 387 NX PHARMAGEN: COMPANY OVERVIEW
  • TABLE 388 EXOPHARM: COMPANY OVERVIEW
  • TABLE 389 EVERZOM: COMPANY OVERVIEW
  • TABLE 390 NANOSOMIX: COMPANY OVERVIEW
  • TABLE 391 CREATIVE BIOLABS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 EXOSOME RESEARCH MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 EXOSOME RESEARCH MARKET: YEARS CONSIDERED
  • FIGURE 3 EXOSOME RESEARCH MARKET: RESEARCH DESIGN
  • FIGURE 4 EXOSOME RESEARCH MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
  • FIGURE 6 EXOSOME RESEARCH MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 7 COMPANY REVENUE ANALYSIS-BASED ESTIMATION: BOTTOM-UP APPROACH (2024)
  • FIGURE 8 REVENUE SHARE ANALYSIS OF THERMO FISHER SCIENTIFIC INC. (2024)
  • FIGURE 9 EXOSOME RESEARCH MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 10 EXOSOME RESEARCH MARKET: TOP-DOWN APPROACH
  • FIGURE 11 EXOSOME RESEARCH MARKET: CAGR PROJECTIONS
  • FIGURE 12 EXOSOME RESEARCH MARKET: DATA TRIANGULATION
  • FIGURE 13 EXOSOME RESEARCH MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 EXOSOME RESEARCH MARKET, BY INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 EXOSOME RESEARCH MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 EXOSOME RESEARCH MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 REGIONAL SNAPSHOT OF EXOSOME RESEARCH MARKET
  • FIGURE 18 HIGH DEMAND FOR PRECISION MEDICINES AND STRONG PHARMACEUTICAL R&D INFRASTRUCTURE TO DRIVE MARKET
  • FIGURE 19 US AND BIOMARKERS COMMANDED LARGEST SHARE OF NORTH AMERICAN EXOSOME RESEARCH MARKET IN 2024
  • FIGURE 20 US TO WITNESS HIGHEST CAGR FROM 2025 TO 2030
  • FIGURE 21 EXOSOME RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 EXOSOME RESEARCH MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 23 INDICATIVE PRICE OF EXOSOME KITS & REAGENTS, BY KEY PLAYER (2024)
  • FIGURE 24 INDICATIVE PRICE OF EXOSOME RESEARCH PRODUCTS, BY REGION (2024)
  • FIGURE 25 EXOSOME RESEARCH MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 26 EXOSOME RESEARCH MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 EXOSOME RESEARCH MARKET: TOP PATENT APPLICANTS/OWNERS AND NUMBER OF PATENTS GRANTED, JANUARY 2014–DECEMBER 2024
  • FIGURE 29 EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 32 EXOSOME RESEARCH MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024
  • FIGURE 33 EXOSOME RESEARCH MARKET: IMPACT OF AI/GEN AI
  • FIGURE 34 NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT
  • FIGURE 35 EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET, 2020–2024 (USD MILLION)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET (2024)
  • FIGURE 38 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 39 EXOSOME RESEARCH MARKET: COMPANY FOOTPRINT
  • FIGURE 40 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 EXOSOME RESEARCH MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 45 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 46 LONZA: COMPANY SNAPSHOT
  • FIGURE 47 DANAHER: COMPANY SNAPSHOT
  • FIGURE 48 BIO-TECHNE: COMPANY SNAPSHOT
  • FIGURE 49 AETHLON MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 50 CREATIVE MEDICAL TECHNOLOGIES HOLDINGS, INC.: COMPANY SNAPSHOT
  • FIGURE 51 SPECTRIS: COMPANY SNAPSHOT
  • FIGURE 52 CAPRICOR THERAPEUTICS, INC.: COMPANY SNAPSHOT

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global exosome research market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the exosome research market. The secondary sources used for this study include the International Chromosome and Genome Society (ICGS), the National Human Genome Research Institute (NHGRI), the Asia Pacific Society of Human Genetics (APSHG), Genetics Society of America (GSA), the European Society of Human Genetics (ESHG), Centers for Common Disease Genomics (CDDG), Center for Cellular and Molecular Biology (CCMB) (India), the Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food & Drug Administration (US FDA). Scientist Magazine, ScienceDirect, research journals, corporate filings such as annual reports, SEC filings, investor presentations, financial statements, press releases, trade, business, professional associations, and others are also pivotal sources. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Comprehensive primary research was undertaken following an initial assessment of the global exosome research market landscape through secondary research. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical & biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand the market dynamics comprehensively.

The following is a breakdown of the primary respondents:

Exosome Research Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both bottom-up and top-down approaches were used to estimate and validate the total size of the exosome research market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • A list of the major global players operating in the exosome research market was generated.
  • The revenues generated from their exosome research product have been determined through annual reports and secondary sources (including paid databases)
  • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment; this was verified using secondary sources and by industry experts.
  • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

Global Exosome Research Market Size: Bottom-up and Top-down Approach

Exosome Research Market

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Exosomes are biomembrane-like vesicles containing protein, miRNA, and lipids that can be delivered to the extracellular milieu (ECM). Exosomes are naturally produced within the body and could be utilized in cell-to-cell communication, molecular therapy for cancer treatment, and the diagnosis of skeletal disorders. They have several advantages in cell-based treatment, which has brought attention to R&D in this field.

Stakeholders

  • Manufacturers and distributors of exosome research products
  • Pharmaceutical and biotechnology companies
  • Contract research organizations (CROs)
  • Contract development & manufacturing organizations (CDMOs)
  • Market research and consulting firms
  • R&D centers
  • Academic & research institutes
  • Regulatory agencies
  • Health insurers and payers
  • Venture capitalists
  • Government organizations
  • Industry associations & professional societies
  • Private & government funding organizations 

Report Objectives

  • To define, describe, and forecast the exosome research market based on offering, indication, application, manufacturing service, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the exosome research market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning five main regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the global exosome research market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the exosome research market
  • To benchmark players within the exosome research market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

Previous Versions of this Report

Exosome Research Market Size, Growth by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User & Region - Global Forecast to 2026

Report Code BT 6939
Published in Jan, 2024, By MarketsandMarkets™

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026

Report Code BT 6939
Published in Mar, 2022, By MarketsandMarkets™

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026

Report Code BT 6939
Published in Feb, 2019, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Exosome Research Market

DMCA.com Protection Status